Conference to focus on biotech funding
|Antonio Giordano, director of the Sbarro Health Research Organization and professor of biology and co-director of the Center for Biotechnology at Temple, experiments in his lab in Main Campus’ Biology-Life Sciences Building. Sbarro, which has patented new research methods that it’s interested in commercializing, will be featured at the Nov. 15 conference on funding strategies for early-stage biotechnology companies.
Biotechnology and entrepreneurship are a natural combination, and the Temple University Council for Entrepreneurship (TUCE) will bring the two together on Nov. 15 for a half-day conference, “The Real Deal: Funding Strategies for Early Stage Biotechnology Companies.”
This event, which is sponsored by the schools of Medicine, Pharmacy, Business and Dentistry and the colleges of Health Professions, Engineering, and Science and Technology, will provide biotechnology startup companies with information on proper funding strategies.
The conference features three panels of presenters. The first panel will focus on the venture capital financing of startup firms in biotechnology.
The second will discuss strategic alliances in the biotechnology industry and explain what a large pharmaceutical company is looking for in a potential early-stage partner.
The third, focusing on investment banks, will present sample case studies of successes as well as failures.
For the complete list of panelists, visit http://sbm.temple.edu/iei/biotech.html.
This conference is the second initiative of TUCE, a cross-school initiative to encourage and promote entrepreneurship at Temple that includes all 17 Temple schools and colleges.
The conference is free for current Temple students, faculty and staff with TUid.
For other guests, the price is $40 at the door.
Breakfast is included.
To register or for more information, call 215-204-3082 or e-mail email@example.com.
WHERE: The Desmond Hotel and Conference Center in Malvern, Pa.
WHEN: Tuesday, Nov. 15, 7:30 a.m. to 11:30 a.m.
- Rebecca Carroll